Filing Details
- Accession Number:
- 0001209191-19-037522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-17 19:05:57
- Reporting Period:
- 2019-06-14
- Accepted Time:
- 2019-06-17 19:05:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636050 | Axovant Gene Therapies Ltd. | AXGT | Pharmaceutical Preparations (2834) | 981333697 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643071 | Atul Pande | C/O Axovant Gene Therapies Ltd. 11 Times Square, 33Rd Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-14 | 3,370 | $5.22 | 3,370 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
